Panagis Polykretis 1 , 2 , Janci C. Lindsay 3 , Patrizia Gentilini 1 , 2 , Nafuko Konishi 4 and Masanori Fukushima 5 1 “Allineare Sanità e Salute” Foundation, Milano 20131, Italy 2 Independent Medical Scientific Commission (CMSi), Milano 20122, Italy 3 Toxicology and Molecular Biology, Toxicology Support Services, LLC., Sealy, TX 77474, USA 4 Osaka Metropolitan University School of Medicine, Osaka 545-0051, Japan 5 Learning Health Society Institute, Nagoya 450-0003, Japan Correspondence to: Keywords: cancer; haematopoietic malignancies; COVID-19; mRNA COVID-19 vaccine Received: December 26, 2025 Accepted: January 19, 2026 Published: February 06, 2026
Polykretis et al. (Fri,) studied this question.